PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells

<p dir="ltr">Cancer stem cells (CSCs) are a small subpopulation bearing self-renewal ability, mediating tumor initiation and propagation. Several molecular pathways, including the PI3K/AKT/mTOR pathway, are known to be aberrantly activated in cancers. In CSCs, PI3K/AKT/mTOR pathway h...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Kirti S. Prabhu (4246144) (author)
مؤلفون آخرون: Shilpa Kuttikrishnan (3520079) (author), Zahwa Mariyam (22504034) (author), Ummu Habeeba (22504037) (author), Anu Jayanthi Panicker (22330129) (author), Tariq Masoodi (8117702) (author), Kulsoom Junejo (9327448) (author), Shahab Uddin (154400) (author)
منشور في: 2025
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513533595615232
author Kirti S. Prabhu (4246144)
author2 Shilpa Kuttikrishnan (3520079)
Zahwa Mariyam (22504034)
Ummu Habeeba (22504037)
Anu Jayanthi Panicker (22330129)
Tariq Masoodi (8117702)
Kulsoom Junejo (9327448)
Shahab Uddin (154400)
author2_role author
author
author
author
author
author
author
author_facet Kirti S. Prabhu (4246144)
Shilpa Kuttikrishnan (3520079)
Zahwa Mariyam (22504034)
Ummu Habeeba (22504037)
Anu Jayanthi Panicker (22330129)
Tariq Masoodi (8117702)
Kulsoom Junejo (9327448)
Shahab Uddin (154400)
author_role author
dc.creator.none.fl_str_mv Kirti S. Prabhu (4246144)
Shilpa Kuttikrishnan (3520079)
Zahwa Mariyam (22504034)
Ummu Habeeba (22504037)
Anu Jayanthi Panicker (22330129)
Tariq Masoodi (8117702)
Kulsoom Junejo (9327448)
Shahab Uddin (154400)
dc.date.none.fl_str_mv 2025-07-17T09:00:00Z
dc.identifier.none.fl_str_mv 10.1007/s00210-025-04297-3
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/PI3_K_AKT_mTOR_pathway_and_its_role_in_breast_cancer_stem_cells/30455789
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Breast cancer
Cancer stem cells
Epithelial–mesenchymal transition
PI3/AKT/mTOR
dc.title.none.fl_str_mv PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Cancer stem cells (CSCs) are a small subpopulation bearing self-renewal ability, mediating tumor initiation and propagation. Several molecular pathways, including the PI3K/AKT/mTOR pathway, are known to be aberrantly activated in cancers. In CSCs, PI3K/AKT/mTOR pathway has been associated with attribution of various properties to cancer cells including stemness characteristics, proliferation, migration, epithelial to mesenchymal transition, and autophagy. Thus, targeting PI3K/AKT/mTOR pathway with novel inhibitors might help to control the growth and proliferation of the breast CSC population. Though many studies have focused on PI3K/AKT/mTOR pathway in breast cancer, limited literature is available on the role of PI3K/AKT/mTOR pathway in breast CSCs. Here, in our present review, we have highlighted the role of the PI3K/AKT/mTOR signaling pathway in breast CSCs and its applications in therapeutic targeting.</p><h2>Other Information</h2><p dir="ltr">Published in: Naunyn-Schmiedeberg's Archives of Pharmacology<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s00210-025-04297-3" target="_blank">https://dx.doi.org/10.1007/s00210-025-04297-3</a></p>
eu_rights_str_mv openAccess
id Manara2_c5f4236e4c936d30ef5ebe1f4cb68c00
identifier_str_mv 10.1007/s00210-025-04297-3
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/30455789
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling PI3 K/AKT/mTOR pathway and its role in breast cancer stem cellsKirti S. Prabhu (4246144)Shilpa Kuttikrishnan (3520079)Zahwa Mariyam (22504034)Ummu Habeeba (22504037)Anu Jayanthi Panicker (22330129)Tariq Masoodi (8117702)Kulsoom Junejo (9327448)Shahab Uddin (154400)Biomedical and clinical sciencesOncology and carcinogenesisPharmacology and pharmaceutical sciencesBreast cancerCancer stem cellsEpithelial–mesenchymal transitionPI3/AKT/mTOR<p dir="ltr">Cancer stem cells (CSCs) are a small subpopulation bearing self-renewal ability, mediating tumor initiation and propagation. Several molecular pathways, including the PI3K/AKT/mTOR pathway, are known to be aberrantly activated in cancers. In CSCs, PI3K/AKT/mTOR pathway has been associated with attribution of various properties to cancer cells including stemness characteristics, proliferation, migration, epithelial to mesenchymal transition, and autophagy. Thus, targeting PI3K/AKT/mTOR pathway with novel inhibitors might help to control the growth and proliferation of the breast CSC population. Though many studies have focused on PI3K/AKT/mTOR pathway in breast cancer, limited literature is available on the role of PI3K/AKT/mTOR pathway in breast CSCs. Here, in our present review, we have highlighted the role of the PI3K/AKT/mTOR signaling pathway in breast CSCs and its applications in therapeutic targeting.</p><h2>Other Information</h2><p dir="ltr">Published in: Naunyn-Schmiedeberg's Archives of Pharmacology<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s00210-025-04297-3" target="_blank">https://dx.doi.org/10.1007/s00210-025-04297-3</a></p>2025-07-17T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1007/s00210-025-04297-3https://figshare.com/articles/journal_contribution/PI3_K_AKT_mTOR_pathway_and_its_role_in_breast_cancer_stem_cells/30455789CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/304557892025-07-17T09:00:00Z
spellingShingle PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells
Kirti S. Prabhu (4246144)
Biomedical and clinical sciences
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Breast cancer
Cancer stem cells
Epithelial–mesenchymal transition
PI3/AKT/mTOR
status_str publishedVersion
title PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells
title_full PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells
title_fullStr PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells
title_full_unstemmed PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells
title_short PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells
title_sort PI3 K/AKT/mTOR pathway and its role in breast cancer stem cells
topic Biomedical and clinical sciences
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Breast cancer
Cancer stem cells
Epithelial–mesenchymal transition
PI3/AKT/mTOR